Journal of Medical Economics, Volume 15, Issue 6 (2012)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 15, Issue 6 (2012)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Volume 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Original Article

Article
Direct medical costs associated with atopic diseases among young children in Thailand
Jarungchit Ngamphaiboon, Thitima Kongnakorn, Patrick Detzel, Krittawan Sirisomboonwong & Radek Wasiak
Pages: 1025-1035
Published online: 14 Jun 2012
AbstractforDirect medical costs associated with atopic diseases among young children in Thailand | Full Text | References | PDF (317.7 KB)
  • 794 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
Comparative effectiveness: beyond the buzz
Lieven Annemans
Pages: 1036-1038
Published online: 19 Nov 2012
First Page PreviewforComparative effectiveness: beyond the buzz | Full Text | References | PDF (64.6 KB)
  • 335 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis
Elise M. Pelletier, Manjiri Pawaskar, Paula J. Smith, Jennie H. Best & Richard H. Chapman
Pages: 1039-1050
Published online: 24 May 2012
AbstractforEconomic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis | Full Text | References | PDF (150.3 KB)
  • 1077 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Letter to the editor

Letter
Letter to the editor
Ángel Sanz Granda, Laura García Jurado & Carlos Polanco Sánchez
Pages: 1051-1053
Published online: 24 May 2012
AbstractforLetter to the editor | Full Text | References | PDF (62.6 KB)
  • 484 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents
Xin Gao, Daniel Wendling, Marc F. Botteman, John A. Carter, Sumati Rao & Mary Cifaldi
Pages: 1054-1063
Published online: 11 Jun 2012
AbstractforClinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents | Full Text | References | PDF (113.2 KB)
  • 1669 Views
  • 35 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia
John Su, Susan Prescott, John Sinn, Mimi Tang, Peter Smith, Ralf G. Heine, Jörg Spieldenner & Michael Iskedjian
Pages: 1064-1077
Published online: 12 Jun 2012
AbstractforCost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia | Full Text | References | PDF (1.8 MB)
  • 726 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access
Article
Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity
M. Haim Erder, James E. Signorovitch, Juliana Setyawan, Hongbo Yang, Kejal Parikh, Keith A. Betts, Jipan Xie, Paul Hodgkins & Eric Q. Wu
Pages: 1078-1087
Published online: 14 Jun 2012
AbstractforIdentifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity | Full Text | References | PDF (333.4 KB)
  • 767 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States
Soyon Lee, Daniel C. Baxter, Brendan Limone, Matthew S. Roberts & Craig I. Coleman
Pages: 1088-1096
Published online: 24 May 2012
AbstractforCost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States | Full Text | References | PDF (347.1 KB)
  • 1569 Views
  • 31 CrossRef citations
  • 0Altmetric
Free Access
Article
A cost-utility study of the use of pregabalin added to usual care in refractory neuropathic pain patients in a Swedish setting
Matthew Prettyjohns, Rebecka Sandelin, Steven Lister & Jan-Rickard Norrefalk
Pages: 1097-1109
Published online: 05 Jul 2012
AbstractforA cost-utility study of the use of pregabalin added to usual care in refractory neuropathic pain patients in a Swedish setting | Full Text | References | PDF (470.4 KB)
  • 414 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO study
Daniela Paola Roggeri, Sandro Mazzaferro, Diego Brancaccio, Giuseppe Cannella, Piergiorgio Messa, Marina Di Luca, Massimo Morosetti, Anna Maria Costanzo, Umberto di Luzio Paparatti, Dante Cornago, Mario Cozzolino, on behalf of the FARO Study Group & on behalf of the FARO Study Group
Pages: 1110-1117
Published online: 06 Jul 2012
AbstractforPharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO study | Full Text | References | PDF (130.7 KB)
  • 547 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Brief report

Article
Comparing the effectiveness of rosuvastatin and atorvastatin in preventing cardiovascular outcomes: estimates using the Archimedes model
C. Andy Schuetz, Andrew van Herick, Peter Alperin, Barbara Peskin, Judith Hsia & Sanjay Gandhi
Pages: 1118-1129
Published online: 06 Jul 2012
AbstractforComparing the effectiveness of rosuvastatin and atorvastatin in preventing cardiovascular outcomes: estimates using the Archimedes model | Full Text | References | PDF (452.6 KB)
  • 1873 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Treatment of candidemia with echinocandins: data on hospital resource use from a real world setting
Rolin L. Wade, Paresh Chaudhari, Rebecca S. Campbell, Harlen D. Hays, Brian H. Nathanson, Jing Yi & David Horn
Pages: 1130-1138
Published online: 13 Jul 2012
AbstractforTreatment of candidemia with echinocandins: data on hospital resource use from a real world setting | Full Text | References | PDF (284.4 KB)
  • 408 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma
Michael K. Wong, Ateesha F. Mohamed, A. Brett Hauber, Jui-Chen Yang, Zhimei Liu, Jaqueline Rogerio & Carlos A. Garay
Pages: 1139-1148
Published online: 18 Jul 2012
AbstractforPatients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinoma | Full Text | References | PDF (559.2 KB) | Supplemental
  • 931 Views
  • 31 CrossRef citations
  • 0Altmetric
Free Access
Article
Fingolimod reduces direct medical costs compared to natalizumab in patients with relapsing–remitting multiple sclerosis in The Netherlands
M. Heisen, M. J. Treur, W. S. van der Hel, S. T. F. M. Frequin, M. T. Groot & B. G. Verheggen
Pages: 1149-1158
Published online: 27 Jul 2012
AbstractforFingolimod reduces direct medical costs compared to natalizumab in patients with relapsing–remitting multiple sclerosis in The Netherlands | Full Text | References | PDF (606.9 KB) | Supplemental
  • 683 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Article
Adherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy
Steven-Huy Han, Wuhua Jing, Edward Mena, Michael Li, Brett Pinsky, Hong Tang, Tony Hebden & Timothy Juday
Pages: 1159-1166
Published online: 30 Jul 2012
AbstractforAdherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy | Full Text | References | PDF (137.2 KB)
  • 682 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access
Article
Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France
Enora Laas, Anne-Lise Vataire, Samuel Aballea, William Valentine, Joseph Gligorov, Elisabeth Chereau & Roman Rouzier
Pages: 1167-1175
Published online: 01 Aug 2012
AbstractforEvaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France | Full Text | References | PDF (251.2 KB)
  • 595 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access
Article
Changes in COPD demographics and costs over 20 years
Christopher M. Blanchette, Anand A. Dalal & Douglas Mapel
Pages: 1176-1182
Published online: 01 Aug 2012
AbstractforChanges in COPD demographics and costs over 20 years | Full Text | References | PDF (163.1 KB)
  • 1031 Views
  • 29 CrossRef citations
  • 0Altmetric
Free Access
Article
Patient and parent preferences for immunoglobulin treatments: a conjoint analysis
Ateesha F. Mohamed, Vikram Kilambi, Michelle P. Luo, Ravi G. Iyer & Josephine M. Li-McLeod
Pages: 1183-1191
Published online: 09 Aug 2012
AbstractforPatient and parent preferences for immunoglobulin treatments: a conjoint analysis | Full Text | References | PDF (388.4 KB)
  • 771 Views
  • 14 CrossRef citations
  • 0Altmetric
Free Access
Article
Elicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis
I. Iqbal, B. Dasgupta, P. Taylor, L. Heron & C. Pilling
Pages: 1192-1200
Published online: 09 Aug 2012
AbstractforElicitation of health state utilities associated with differing durations of morning stiffness in rheumatoid arthritis | Full Text | References | PDF (184.8 KB)
  • 504 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Article
The societal burden of pain in Germany: Health-related quality-of-life, health status and direct medical costs
Paul C. Langley
Pages: 1201-1215
Published online: 10 Aug 2012
AbstractforThe societal burden of pain in Germany: Health-related quality-of-life, health status and direct medical costs | Full Text | References | PDF (129 KB)
  • 763 Views
  • 28 CrossRef citations
  • 0Altmetric
Free Access

Erratum

Correction
Erratum
Page: 1216
Published online: 19 Nov 2012
AbstractforErratum | Full Text | PDF (40 KB)
  • 298 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel
Tanya M. Burton, Michael Lacey, Fang Liu, Yanni Yu, Maria Laura Monsalvo, Kathy Lang & Stephen Sander
Pages: 1217-1225
Published online: 17 Aug 2012
AbstractforOne-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel | Full Text | References | PDF (220.8 KB)
  • 560 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

The efficiency of TAVI in intermediate and low-risk Japanese patients.
Panagiotis Petrou
Editorial | Published online: 25 May 2024
Open Access
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom
Mafalda Ramos et al.
Article | Published online: 17 May 2024
Open Access
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel et al.
Article | Published online: 13 May 2024
Open Access
Balancing innovation and ethics in AI governance for health technology assessment
João L. Carapinha et al.
Editorial | Published online: 13 May 2024
Open Access
View all latest articles